Search

Kemira Oyj

Fermé

19.02 0.05

Résumé

Variation du prix de l'action

24h

Actuel

Min

19.01

Max

19.06

Chiffres clés

By Trading Economics

Revenu

-7.3M

54M

Ventes

-15M

693M

P/E

Moyenne du Secteur

13.695

85.308

BPA

0.39

Rendement du dividende

3.62

Marge bénéficiaire

7.845

Employés

4,766

EBITDA

135M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

3.62%

3.17%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

47K

2.9B

Ouverture précédente

18.97

Clôture précédente

19.02

Kemira Oyj Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

31 oct. 2025, 17:40 UTC

Acquisitions, Fusions, Rachats

Orange to Buy Lorca's 50% Stake in MasOrange for $4.9 Billion

1 nov. 2025, 12:56 UTC

Résultats

Berkshire's Quarterly Earnings Rise After Insurance Results Improve -- WSJ

1 nov. 2025, 12:56 UTC

Résultats
Acquisitions, Fusions, Rachats

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 nov. 2025, 12:20 UTC

Résultats
Acquisitions, Fusions, Rachats

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 nov. 2025, 12:19 UTC

Résultats
Acquisitions, Fusions, Rachats

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 nov. 2025, 08:20 UTC

Market Talk

Financial Services Roundup: Market Talk

1 nov. 2025, 08:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

1 nov. 2025, 00:10 UTC

Résultats

Trouble on The Strip -- Barrons.com

31 oct. 2025, 23:09 UTC

Résultats

Review & Preview: October Surprise -- Barrons.com

31 oct. 2025, 22:44 UTC

Acquisitions, Fusions, Rachats

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31 oct. 2025, 21:25 UTC

Market Talk
Acquisitions, Fusions, Rachats

Pfizer Says Novo Nordisk's Metsera Bid Won't Pass Antitrust Laws -- Market Talk

31 oct. 2025, 21:20 UTC

Acquisitions, Fusions, Rachats

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- Update

31 oct. 2025, 21:12 UTC

Acquisitions, Fusions, Rachats

Pfizer Sues Metsera, Novo Nordisk, Claiming Novo Nordisk Takeover Offer Isn't Superior -- WSJ

31 oct. 2025, 21:12 UTC

Acquisitions, Fusions, Rachats

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31 oct. 2025, 21:12 UTC

Acquisitions, Fusions, Rachats

Pfizer Seeks Order Blocking Metsera From Terminating Its Merger Deal With Pfizer -- WSJ

31 oct. 2025, 20:51 UTC

Acquisitions, Fusions, Rachats

Another Rare-Earth Stock Jumps on Government Deal -- Barrons.com

31 oct. 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

31 oct. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 oct. 2025, 20:50 UTC

Market Talk
Résultats

Auto & Transport Roundup: Market Talk

31 oct. 2025, 20:46 UTC

Acquisitions, Fusions, Rachats

Pfizer: Files Lawsuit Against Metsera and Its Directors and Novo Nordisk for Breach of Merger Agreement

31 oct. 2025, 20:22 UTC

Résultats

Amazon Stock Hits New Record. What Was So Good in Its Earnings Report. -- Barrons.com

31 oct. 2025, 20:02 UTC

Résultats

Meta Faces a Sudden Reckoning. How Big Tech Earnings Are Reshaping the AI Race. -- Barrons.com

31 oct. 2025, 19:55 UTC

Market Talk

Crude Futures Fall for Third Straight Month -- Market Talk

31 oct. 2025, 19:54 UTC

Acquisitions, Fusions, Rachats

Pfizer: FTC Granted Early Termination of Waiting Period >PFE

31 oct. 2025, 19:54 UTC

Acquisitions, Fusions, Rachats

Pfizer: Receives Early Clearance From FTC for Metsera Acquisition

31 oct. 2025, 19:26 UTC

Market Talk

U.S. Natural Gas Rises on Winter Outlook, Strong LNG -- Market Talk

31 oct. 2025, 18:30 UTC

Résultats

These Stocks Are Moving the Most Today: Amazon, Nvidia, Apple, Netflix, Exxon, DexCom, Coinbase, Reddit, Newell Brands, and More -- Barrons.com

31 oct. 2025, 18:23 UTC

Market Talk

Gold Edges Lower for the Day, Closes October Positive -- Market Talk

31 oct. 2025, 18:09 UTC

Résultats

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

31 oct. 2025, 18:08 UTC

Résultats

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

Kemira Oyj prévision

Éléments financiers

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Kemira Oyj

Kemira Oyj operates as a chemicals company in Finland, rest of Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates in two segments, Pulp & Paper and Industry & Water. The Pulp & Paper segment develops and commercializes pulp and paper, as well as a range of products for paper wet-end, including packaging, and board and tissue products. The Industry & Water segment offers coagulants, polymers, and other water treatment chemicals. Kemira Oyj was founded in 1920 and is headquartered in Helsinki, Finland.
help-icon Live chat